EntrepreneursOfLA icon
Original Startups

SPARK at USC: Lessons for LA Scientists Turning Lab Work Into Startups

USC's new SPARK program gives biomedical teams up to $50K a year in milestone funding plus mentors. Lessons for LA researchers weighing a startup or license.

SPARK at USC: Lessons for LA Scientists Turning Lab Work Into Startups

Some of the most valuable startup ideas in Los Angeles never leave the lab. A researcher makes a promising discovery, publishes it, wins another grant and moves on, because nobody in the building has walked the path from a result on a bench to a product a patient can use. A new program at USC is trying to close that gap, and it offers lessons for any LA scientist who is quietly wondering whether their work could become a company.

What SPARK at USC is

SPARK at USC, announced by the USC Viterbi School of Engineering on Nov. 11, gives early-stage biomedical teams funding, mentoring and a practical road map for turning research into potential treatments. It is co-directed by Eun Ji Chung, an associate professor of biomedical engineering and chemical engineering who founded a kidney-disease therapeutics company, Silver Spur Therapeutics, from work in her USC lab, and Juliane Glaeser, director of translational and collaborative research programs at USC Stem Cell in the Keck School of Medicine.

The key details, according to USC:

  • Who can apply: USC faculty, staff, students and postdoctoral researchers, plus researchers at Children's Hospital Los Angeles and outside groups, as long as the technology comes from a USC laboratory.
  • Funding: selected teams can receive up to $50,000 a year, released as they hit milestones, with the option to seek a second year.
  • Mentoring: advisers drawn from biotech, pharma, medicine, investing and regulatory affairs, matched to each project and bound by confidentiality agreements.
  • Backers: the program grew out of Chung's Transformative Center for Nanomedicine and Drug Delivery and is supported by the USC Stevens Center for Innovation and USC Stem Cell.

The inaugural class has two teams. One is developing engineered exosomes, tiny cell-made packages, designed to trigger immune responses against cancer that has spread to the bone. The other is working on a potential treatment for Duchenne muscular dystrophy that breaks down a harmful protein.

A model with a long track record

SPARK did not start in Los Angeles. Chung and Glaeser studied the SPARK program at Stanford, founded in 2006, which pairs academic researchers with volunteer industry experts. Stanford says that more than half of its SPARK projects have moved into clinical or commercial development, and that as of 2018, 32 projects had become startups and 16 had been licensed to existing companies. The model has since spread internationally as SPARK Global, with each site adapting it locally.

USC's version focuses on the earliest stage of discovery, where its leaders see the biggest local need.

Lessons for LA's lab-born founders

You do not need to be at USC to borrow the thinking behind the program. A few ideas stand out.

A startup is only one possible exit. SPARK at USC explicitly does not push every team to form a company. A discovery might be licensed to an existing business, developed with a partner or tested in a university clinical trial. For many researchers, licensing is faster and less risky than raising venture money and hiring a CEO. Decide which path fits the science, not which one sounds most exciting.

Milestone money forces clarity. Funding released only when a team hits defined goals is common in translational programs, and it is good practice even when you are spending your own grant dollars. Define the next experiment that would most change an investor's or licensee's mind, put a date and budget on it, and treat it like a gate.

Ask the commercial questions early. According to USC, SPARK mentors push teams on a short list of questions: Who are the patients? How will the treatment be given? Can it be manufactured at scale? What evidence will regulators or investors need? Most academic projects stall on one of those, not on the core science. Writing honest answers, even rough ones, is the cheapest market research a lab can do.

Your trainee may be your future CEO. The program lets trainees serve as co-principal investigators alongside faculty, and Chung has said that a student could become the leader of a startup. Founders who are faculty often keep their academic jobs, so identifying a postdoc or graduate student with business interest early can determine whether a spinout ever happens.

Talk to your tech transfer office before you talk to investors. At most universities, inventions made in campus labs are subject to institutional intellectual property policies. Before you pitch, file an invention disclosure, understand who owns what and ask about patent timing. Publishing first can limit patent options.

Where this fits in LA's startup scene

Los Angeles is better known for aerospace, consumer brands and entertainment tech, but it is also home to major research universities and hospitals. Programs like SPARK matter because the hardest gap in life sciences is often the first one: getting from a paper to a project that an industry partner can evaluate.

For now, SPARK at USC is small, two teams in its first year, and its leaders say success will be measured less by deal counts than by whether teams gain the tools to keep ideas moving toward patients. For LA founders and investors watching the region's life-sciences pipeline, it is one to follow.

← More Startups